Immunovaccine Announces Results of 2014 Annual General Meeting HALIFAX, NOVA SCOTIA--(Marketwired - Apr 24, 2014) - Immunovaccine Inc...
HALIFAX, NOVA SCOTIA--(Marketwired - April 8, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE:IMV), a clinical stage vaccine...
Immunovaccine Highlights Enhanced Anti-Tumor Activity of Cancer Vaccine Combination Therapies in Presentation at the 2014 AACR Annual...
Immunovaccine to Present Data on Cancer Vaccine Combination Therapies at the 2014 AACR Annual Meeting Combining with cyclophosphamide and the...
HALIFAX, NOVA SCOTIA and SAN DIEGO, CALIFORNIA--(Marketwired - April 1, 2014) - Immunovaccine Inc. ("Immunovaccine") (TSX VENTURE:IMV) and Pfenex...
Immunovaccine Announces 2013 Year-End Results HALIFAX, NOVA SCOTIA--(Marketwired - Mar 17, 2014) - Immunovaccine Inc. (TSX-VENTURE:IMV), a...
Llew Keltner, US Biotech Industry Adviser, Joins Board of Immunovaccine HALIFAX, NOVA SCOTIA--(Marketwired - Jan 20, 2014) - Immunovaccine...
Immunovaccine Grants Stock Options HALIFAX, NOVA SCOTIA--(Marketwired - Jan 20, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV" or "the...
HALIFAX, NOVA SCOTIA--(Marketwired - Jan. 20, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV" or "the Company") (TSX VENTURE:IMV), a clinical...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.